| Mrs Priscilla R Greene, FHNP | |
|
172 Mj Taylor Rd, Adel, GA 31620-3497 | |
| (229) 896-5200 | |
| (229) 388-9855 |
| Full Name | Mrs Priscilla R Greene |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 28 Years |
| Location | 172 Mj Taylor Rd, Adel, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184731564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN117817NP (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cook Medical Center A Campus Of Tift Reg Med Ctr | Adel, GA | Hospital |
| Tift Regional Medical Center | Tifton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tift Regional Health System Inc | 2062745169 | 298 |
News Archive
Researchers have developed a novel tool for determining the sensitivity of bone healing to inhibition of the Wnt signaling pathway and have validated its use in a study of bone regeneration in mice.
Unigloves new Fortified single use gloves incorporate silver ion technology from BioCote, which has been scientifically proven to destroy 90% of harmful bacteria within just 15 minutes and 99.5% in only two hours.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
› Verified 3 days ago
| Entity Name | Tift Regional Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790280857 PECOS PAC ID: 5193619971 Enrollment ID: O20040212000064 |
News Archive
Researchers have developed a novel tool for determining the sensitivity of bone healing to inhibition of the Wnt signaling pathway and have validated its use in a study of bone regeneration in mice.
Unigloves new Fortified single use gloves incorporate silver ion technology from BioCote, which has been scientifically proven to destroy 90% of harmful bacteria within just 15 minutes and 99.5% in only two hours.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
› Verified 3 days ago
| Entity Name | Tift Regional Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881203305 PECOS PAC ID: 2062745169 Enrollment ID: O20200217002409 |
News Archive
Researchers have developed a novel tool for determining the sensitivity of bone healing to inhibition of the Wnt signaling pathway and have validated its use in a study of bone regeneration in mice.
Unigloves new Fortified single use gloves incorporate silver ion technology from BioCote, which has been scientifically proven to destroy 90% of harmful bacteria within just 15 minutes and 99.5% in only two hours.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Priscilla R Greene, FHNP 907 18th St E Ste 400, Tifton, GA 31794-3684 Ph: (229) 353-3422 | Mrs Priscilla R Greene, FHNP 172 Mj Taylor Rd, Adel, GA 31620-3497 Ph: (229) 896-5200 |
News Archive
Researchers have developed a novel tool for determining the sensitivity of bone healing to inhibition of the Wnt signaling pathway and have validated its use in a study of bone regeneration in mice.
Unigloves new Fortified single use gloves incorporate silver ion technology from BioCote, which has been scientifically proven to destroy 90% of harmful bacteria within just 15 minutes and 99.5% in only two hours.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
› Verified 3 days ago
Alexander Warren, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 110 S Hutchinson Ave, Adel, GA 31620 Phone: 229-896-2124 | |
Walter Stone, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 172 Mj Taylor Rd, Adel, GA 31620 Phone: 229-896-8500 | |
Tammy Charlene Carter, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 602 N Hutchinson Ave, Adel, GA 31620 Phone: 229-848-5073 | |
Melissa Michelle Roberts, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 172 Mj Taylor Rd, Adel, GA 31620 Phone: 229-896-3424 | |
David K. Vickers, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 103 James St, Adel, GA 31620 Phone: 229-896-3424 Fax: 229-896-3838 | |
Caroline Hendley, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 172 Mj Taylor Rd, Adel, GA 31620 Phone: 229-896-8500 |